The cystine/glutamate antiporter regulates dendritic cell differentiation and antigen presentation.
The major cellular antioxidant glutathione is depleted during HIV infection and in obesity. Although the consequence of glutathione depletion on immune function is starting to emerge, it is currently not known whether glutathione dysregulation influences the differentiation and maturation of dendritic cells (DCs). Moreover, the effect of glutathione depletion on DC effector functions, such as Ag presentation, is poorly understood. Glutathione synthesis depends on the cystine/glutamate antiporter, which transports the rate-limiting precursor cystine into the cell in exchange for glutamate. In this paper, we present a detailed study of antiporter function in DCs and demonstrate a role for the antiporter in DC differentiation and cross-presentation. We show that the antiporter is the major mechanism for transport of cystine and glutamate and modulates the intracellular glutathione content and glutathione efflux from DCs. Blocking antiporter-dependent cystine transport decreases intracellular glutathione levels, and these effects correlate with reduced transcription of the functional subunit of the antiporter. We further demonstrate that blocking antiporter activity interferes with DC differentiation from monocyte precursors, but antiporter activity is not required for LPS-induced phenotypic maturation. Finally, we show that inhibiting antiporter uptake of cystine interferes with presentation of exogenous Ag to class II MHC-restricted T cells and blocks cross-presentation on MHC class I. We conclude that aberrant antiporter function disrupts glutathione homeostasis in DCs and may contribute to impaired immunity in the diseased host.
D'Angelo
June A
JA
Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Science Center, New Orleans, LA 70112, USA.
Dehlink
Eleonora
E
Platzer
Barbara
B
Dwyer
Peter
P
Circu
Magdalena L
ML
Garay
Jone
J
Aw
Tak Yee
TY
Fiebiger
Edda
E
Dickinson
Bonny L
BL
D027182:Amino Acid Transport System y+ / Q000037:antagonists & inhibitors / Q000502:physiology*; D000818:Animals; D017951:Antigen Presentation / Q000235:genetics / Q000276:immunology*; D001692:Biological Transport / Q000276:immunology; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology*; D002478:Cells, Cultured; D045142:Cross-Priming / Q000235:genetics / Q000276:immunology; D003553:Cystine / Q000378:metabolism; D003713:Dendritic Cells / Q000166:cytology* / Q000276:immunology* / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D005978:Glutathione / Q000037:antagonists & inhibitors / Q000378:metabolism; D006706:Homeostasis / Q000276:immunology; D006801:Humans; D007424:Intracellular Fluid / Q000276:immunology / Q000378:metabolism; D008070:Lipopolysaccharides / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010047:Ovalbumin / Q000276:immunology / Q000378:metabolism
D027182:Amino Acid Transport System y+; D008070:Lipopolysaccharides; C118895:SLC7A11 protein, human; D018698:Glutamic Acid; D003553:Cystine; D010047:Ovalbumin; D005978:Glutathione